Location History:
- Plainsboro, NJ (US) (1997 - 1998)
- Hopewell, NJ (US) (2005 - 2011)
Company Filing History:
9 out of 101 
4 out of 3,684 
2 out of 52 Years Active: 1997-2011
Title: Ian Henderson: Innovator in Pharmaceutical Chemistry
Introduction
Ian Henderson is a notable inventor based in Hopewell, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work primarily focuses on developing innovative compounds that address various medical conditions.
Latest Patents
Henderson's latest patents include groundbreaking research on N-heterocyclic inhibitors of TNF-alpha expression. These N-heterocyclic compounds are designed to block cytokine production by inhibiting p38 kinase. The patents disclose methods of production, pharmaceutical compositions, and treatment methods for conditions associated with inappropriate p38 kinase activity or TNF-alpha expression. Another significant patent involves 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders. These compounds are formulated to treat and prevent conditions such as obesity and diabetes.
Career Highlights
Throughout his career, Ian Henderson has worked with prominent companies in the pharmaceutical industry, including Pharmacopeia Inc. and Bristol-Myers Squibb Company. His expertise in drug development has led to advancements in therapeutic options for various diseases.
Collaborations
Henderson has collaborated with notable colleagues, including John J. Baldwin and Gulzar Ahmed. These partnerships have contributed to the success of his innovative projects and patents.
Conclusion
Ian Henderson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the development of treatments for significant health issues.